PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, The Canberra Hospital, Canberra, Australian Capital Territory, Australia.\', \'ANU Medical School, Australian National University, Canberra, Australian Capital Territory, Australia.\', \'Department of Medical Oncology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.\', \'Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.\', \'Border Medical Oncology, Albury-Wodonga Health, Albury, New South Wales, Australia.\', \'University of NSW Rural Medical School, Albury, New South Wales, Australia.\', \'Medical Oncology, Nepean Cancer Care Centre, Nepean Hospital, Sydney, New South Wales, Australia.\', \'Department of Oncology, Monash Health, Melbourne, Victoria, Australia.\', \'School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/imj.15339
?:hasPublicationType
?:journal
  • Internal medicine journal
is ?:pmid of
?:pmid
?:pmid
  • 34155756
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.748
?:rankingScore_hIndex
  • 60
is ?:relation_isRelatedTo_publication of
?:title
  • Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumours.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all